India to Philippines: Losartan Export Trade Route

The India to Philippines Losartan corridor is one of India's established pharmaceutical export routes, with 717 shipments documented worth a combined $32.0M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 30% of all export value, reflecting the consolidated nature of India's losartan manufacturing sector.

Across 74 active suppliers, the average shipment value stands at $44.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with losartan's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 11.5%, placing it at rank #4 among India's top losartan export destinations globally.

On the import side, key buyers of Indian losartan in Philippines include NELPA LIFESCIENCES INC, UNILAB INC, UNILAB INC and 84 others. NELPA LIFESCIENCES INC is the single largest importer with 78 shipments valued at $11.5M USD.

India's losartan exports to Philippines are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 62 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 74 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED, BDH HEALTHCARE PRIVATE LIMITED, FORTCAPS LABORATORIES PRIVATE LIMITED — together account for 51% of total trade value on this route. The average shipment value of $44.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products harmless medicine, saphlor 50 (losartan potassium tablets usp 50 mg ) (pack 10 x 10 t) and pharmaceutical products harmless medicine, saphlor-100 (losartan potassium tablets usp 100mg) (pack of 24000 x10x10 t), suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NELPA LIFESCIENCES INC is the largest importer with 78 shipments worth $11.5M USD — representing 36% of all losartan imports from India on this route. A total of 87 buyers are active on this corridor.